Regeneron Pharmaceuticals

REGN · United States · Biotechnology · matched S&P 500 member. Follow its market-weight contribution.

Historical time machine

Historical observation

20182026

Universe weight

0.085%

12M weight contribution

+0.084 pp

3M weight contribution

-0.121 pp

12M price return

+1.3%

Share of matched S&P 500 members

Monthly observations through Feb 2021

Company price index

A separate dimension from market allocation

Historical observations

Most recent 24 observations at or before the selected month

Month	Market cap	Universe weight	12M weight change	12M return	Above 6M weight average
Feb 2021	$42.3bn	0.085%	+0.084 pp	+1.3%	No
Jan 2021	$47.3bn	0.113%	-0.043 pp	+49.1%	No
Dec 2020	$45.4bn	0.184%	+0.011 pp	+28.7%	Yes
Nov 2020	$48.5bn	0.206%	+0.031 pp	+39.8%	Yes
Oct 2020	$51.1bn	0.242%	+0.092 pp	+77.5%	Yes
Sep 2020	$52.6bn	0.000%	-0.138 pp	+101.8%	No
Aug 2020	$58.2bn	0.000%	-0.148 pp	+113.7%	No
Jul 2020	$59.4bn	0.000%	-0.152 pp	+107.4%	No
Jun 2020	$58.6bn	0.000%	-0.158 pp	+99.2%	No
May 2020	$57.6bn	0.000%	-0.165 pp	+103.1%	No
Apr 2020	$49.4bn	0.277%	+0.097 pp	+53.3%	Yes
Mar 2020	$45.9bn	0.000%	-0.221 pp	+18.9%	No
Feb 2020	$41.8bn	0.000%	-0.234 pp	+3.2%	No
Jan 2020	$31.8bn	0.157%	+0.024 pp	-21.3%	No
Dec 2019	$35.3bn	0.173%	+0.048 pp	+0.5%	Yes
Nov 2019	$34.7bn	0.175%	+0.061 pp	+0.9%	Yes
Oct 2019	$28.8bn	0.150%	+0.042 pp	-9.7%	No
Sep 2019	$26.1bn	0.138%	+0.017 pp	-31.3%	No
Aug 2019	$27.3bn	0.148%	+0.025 pp	-28.7%	No
Jul 2019	$28.6bn	0.152%	-0.049 pp	-17.2%	No
Jun 2019	$29.4bn	0.159%	-0.038 pp	-9.3%	No
May 2019	$28.3bn	0.165%	-0.006 pp	+0.5%	No
Apr 2019	$32.2bn	0.180%	+0.004 pp	+13.0%	Yes
Mar 2019	$38.6bn	0.222%	+0.023 pp	+19.2%	Yes

Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.